4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014642
Director sold 39,272 shares at $25.39 ($997,195)
- Director acquired 39,272 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Leonard Keith R · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +27,052 | $8.63 | $233,459 | 49,175 | D |
| 2026-03-02 | Exercise or conversion : show line 2 in the form 10b5-1 | +12,220 | $7.51 | $91,772 | 61,395 | D |
| 2026-03-02 | Sale : show line 3 in the form 10b5-1 | −39,272 | $25.39 | $997,195 | 22,123 | D |
| Open-market sales · 39,272 sh · avg $25.39 · $997,195 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −27,052 | 0 | D |
| 2026-03-02 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −12,220 | 0 | D |
Loading xslF345X05/wk-form4_1772659056.xml…